Herein, we examined TGF-β/Smad3 protein levels to investigate whether they participated in CoCl2 hypoxia-induced peritoneal fibrosis and the therapeutic mechanisms of Canagliflozin. The gene discussed is TGFB1; the disease is Peritoneal Fibrosis.